TITLE

Glaxo SmithKline gives nod to M&C Saatchi

AUTHOR(S)
Linnett, Richard; Goetzl, David
PUB. DATE
July 2000
SOURCE
Advertising Age;7/31/2000, Vol. 71 Issue 32, Preceding p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that the merged companies of Glaxo Wellcome and SmithKline Beecham have awarded corporate image work to M& C Saatchi to promote their new entity, GlaxoSmithKline in the United States and other countries worldwide. The company aims to promote the unit as the world's second-largest drug company.
ACCESSION #
3382584

 

Related Articles

  • Glaxo SmithKline Merge Into World's Biggest Drug Firm. Hetherington, Janet L. // Ageing International;Winter99, Vol. 25 Issue 3, p4 

    Provides information on the merger between drug companies Glaxo Wellcome and SmithKline Beecham which created Glaxo SmithKline PLC. Implications of the merger to the drug industry; Restructuring activities as a result of the merger; Plans of the merger partners.

  • GlaxoSmithKline Merger Completed As Trading for New Company Begins.  // Chemical Market Reporter;01/01/2001, Vol. 259 Issue 1, p11 

    Reports that GlaxoSmithKline PLC, the merger company of Glaxo Wellcome and SmithKline Beecham, has began trading on the New York and London Stock Exchanges following the completion of the merger process in December 2000. Approval of the merger; Sales of GlaxoSmithKline; Products of the merged...

  • Glaxo shops called in for evaluations. Goetzl, David // Advertising Age;5/14/2001, Vol. 72 Issue 20, p1 

    The article reports that GlaxoSmithKline is asking advertising agencies to provide information about their advertising work for the company to monitor spending and possible reduce the amount of fees they pay to the agencies. Glaxo Wellcome and SmithKline Beecham has announced its cost savings...

  • GSK Faces Bribe Charges, Changing of the Guard. Gopal, Kevin // Pharmaceutical Executive;Apr2002, Vol. 22 Issue 4, p20 

    Reports on the allegations that pharmaceutical company SmithKline Beecham has paid bribes to hospital doctors between 1997 and 1999. Number of company employees who are under suspicion in the case; Details of the merger between Glaxo Wellcome and SmithKline Beecham in 2000; Information on the...

  • The Billion Dollar Pyramid. Ansell, John // Pharmaceutical Executive;Aug2000, Vol. 20 Issue 8, p64 

    Considers the challenges to the merger strategy of pharmaceutical companies Glaxo Wellcome and SmithKline Beecham. Analysis of Glaxo Wellcome mergers from 1995 to 2000; Overview of the total pharmaceutical market in 1998; Challenge in the global sales of the Glaxo-SmithKline merger.

  • Merger mania isn't so mad. Fleming, Stewart // New Statesman;02/06/98, Vol. 127 Issue 4371, p27 

    Discusses how the merger between Glaxo Wellcome and SmithKline Beecham will fare politically and economically in Great Britain. How the `Sunday Times' analyzes the merger; Research and development projects conducted by Glaxo; Need for a political response by the merger.

  • Drug company merger should benefit research. Labreque, George // BMJ: British Medical Journal (International Edition);02/14/98, Vol. 316 Issue 7130, p494 

    Focuses on the proposed merger of Glaxo Wellcome and SmithKline Beecham. Implications of the move; Reasons behind the increase in pharmaceutical mergers.

  • Sole strength. Gopal, Kevin // Pharmaceutical Executive;May98, Vol. 18 Issue 5, p30 

    Highlights the failed merger of SmithKline Beecham (SB) with Glaxo Wellcome (GW). Description of drugs and vaccines of SB; Comments on the failed deal; List of drugs in clinical trials; Progress in discovery technologies of SB.

  • Merger of Glaxo Wellcome and SmithKline Beecham creates pharmaceutical giant. Abbott, Alison // Nature;1/20/2000, Vol. 403 Issue 6767, p232 

    Reports on the merger of British pharmaceutical companies, Glaxo Wellcome Inc. and SmithKline Beecham Corp. Combined drug and vaccine portfolios of the companies; Stock market value; Investments in research; Employed research staff; Scientific campuses; Genome research focus.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics